本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Invivyd, Inc.

0.7200
-0.0858-10.65%
盘后0.74300.0230+3.19%17:40 EDT
成交量:126.10万
成交额:94.41万
市值:8,612.35万
市盈率:-0.37
高:0.8300
开:0.8200
低:0.7200
收:0.8058
数据加载中...

公司资料

公司名字:
Invivyd, Inc.
交易所:
NASDAQ
成立时间:
2020
员工人数:
95
公司地址:
1601 Trapelo Road,Suite 178,Waltham,Massachusetts,United States
邮编:
02451
电话:
传真:
- -
简介:
Invivyd, Inc.于2020年6月3日在特拉华州成立。该公司是一家处于商业阶段的公司,其使命是快速、永久地提供基于抗体的疗法,以保护脆弱人群免受流行病毒威胁的破坏性后果,从SARS-CoV-2开始。该公司专有的INVYMAB平台方法将最先进的病毒监测和预测建模与先进的抗体工程相结合。INVYMAB旨在促进快速、连续产生新的单克隆抗体(“MAB”),以跟上不断演变的病毒威胁。

董事

名称
职位
Tillman U. Gerngross
Co-Founder, Chief Executive Officer and Director
Rene Russo
Co-Founder, Director and Chair of the Board
Ajay Royan
Director
Anand Shah
Director
Howard Mayer
Director
Michael Wyzga
Director
Terrance McGuire
Director
Tom Heyman
Director

股东

名称
职位
Tillman U. Gerngross
Co-Founder, Chief Executive Officer and Director
David Hering
Chief Operating Officer
Jane P. Henderson
Chief Financial Officer
Elham. Hershberger
Chief Development Officer
Lynn Connolly
Chief Medical Officer
Rebecca Dabora
Chief Technology & Manufacturing Officer
Rene Russo
Co-Founder, Director and Chair of the Board